Poliovirus Receptor Antikörper (AA 32-141)
Kurzübersicht für Poliovirus Receptor Antikörper (AA 32-141) (ABIN562543)
Target
Alle Poliovirus Receptor (PVR) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 32-141
-
Verwendungszweck
- Mouse polyclonal antibody raised against a partial recombinant PVR.
-
Sequenz
- QAPTQVPGFL GDSVTLPCYL QVPNMEVTHV SQLTWARHGE SGSMAVFHQT QGPSYSESKR LEFVAARLGA ELRNASLRMF GLRVEDEGNY TCLFVTFPQG SRSVDIWLRV
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- PVR (NP_006496, 32 a.a. ~ 141 a.a) partial recombinant protein with GST tag.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 50 % glycerol
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
- Poliovirus Receptor (PVR)
-
Andere Bezeichnung
- PVR
-
Hintergrund
-
Full Gene Name: poliovirus receptor
Synonyms: CD155,FLJ25946,HVED,NECL5,Necl-5,PVS,TAGE4 -
Gen-ID
- 5817
-
NCBI Accession
- NM_006505
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Cancer Immune Checkpoints, SARS-CoV-2 Protein Interaktom
Target
-